Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

557 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studies.
Körholz D, Claviez A, Hasenclever D, Kluge R, Hirsch W, Kamprad F, Dörffel W, Wickmann L, Papsdorf K, Dieckmann K, Kahn T, Mauz-Körholz C, Dannenberg C, Pötter R, Brosteanu O, Schellong G, Sabri O. Körholz D, et al. Among authors: dieckmann k. Klin Padiatr. 2004 May-Jun;216(3):150-6. doi: 10.1055/s-2004-822627. Klin Padiatr. 2004. PMID: 15175959
Up-front centralized data review and individualized treatment proposals in a multicenter pediatric Hodgkin's disease trial with 71 participating hospitals: the experience of the German-Austrian pediatric multicenter trial DAL-HD-90.
Dieckmann K, Pötter R, Wagner W, Prott FJ, Hörnig-Franz I, Rath B, Schellong G. Dieckmann K, et al. Radiother Oncol. 2002 Feb;62(2):191-200. doi: 10.1016/s0167-8140(01)00456-x. Radiother Oncol. 2002. PMID: 11937246 Clinical Trial.
Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.
Dieckmann K, Pötter R, Hofmann J, Heinzl H, Wagner W, Schellong G; Pediatric Cooperative Hodgkin Disease Study Group of the GPOH. Dieckmann K, et al. Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):644-52. doi: 10.1016/s0360-3016(03)00125-1. Int J Radiat Oncol Biol Phys. 2003. PMID: 12788169
[Requirements and performance profile of the Paediatric Radiation Oncology Working Group (APRO): evaluation of the present situation and description of future developments].
Kortmann RD, Bongartz R, Dieckmann K, Dunst J, Flentje M, Gademann G, Christiansen H, Kamprad FH, Karstens JH, Pape H, Rühl U, Schmidt BF, Willich N, Schulz-Ertner D, Schwarz R, Timmermann B, Pohl F, Klingebiel T, Jürgens H, Rübe C. Kortmann RD, et al. Among authors: dieckmann k. Klin Padiatr. 2007 May-Jun;219(3):166-72. doi: 10.1055/s-2007-973855. Klin Padiatr. 2007. PMID: 17525911 German.
Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study.
Mauz-Körholz C, Hasenclever D, Dörffel W, Ruschke K, Pelz T, Voigt A, Stiefel M, Winkler M, Vilser C, Dieckmann K, Karlén J, Bergsträsser E, Fosså A, Mann G, Hummel M, Klapper W, Stein H, Vordermark D, Kluge R, Körholz D. Mauz-Körholz C, et al. Among authors: dieckmann k. J Clin Oncol. 2010 Aug 10;28(23):3680-6. doi: 10.1200/JCO.2009.26.9381. Epub 2010 Jul 12. J Clin Oncol. 2010. PMID: 20625128
557 results